Dernières nouvelles pour MiMedx Group (NASDAQ:MDXG) Stock

MiMedx Group

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

MIMEDX GROUP INC

MiMedx Group Inc

News

Press Releases

MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26

Earnings

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Health Care

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

MDXG

Akebia Therapeutics

AnaptysBio

Ardelyx

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

CareDx

Cidara Therapeutics

Geron

Immunome

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Jyong Biotech

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Nurix Therapeutics

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Arcus Biosciences

Replimune Group

Sana Biotechnology

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Spyre Therapeutics

Verve Therapeutics

Vir Biotechnology

Zymeworks

Cantor Fitzgerald

Craig-Hallum

HC Wainwright & Co.

Lake Street

Mizuho

Comments

MiMedx Group

Actualités

Dernières nouvelles pour MiMedx Group (NASDAQ:MDXG) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL